San Francisco, 15 November 2018 , Global In-Vitro Fertilization (IVF) market is
expected to reach USD 27 billion by 2022, according to a new report by Grand
View Research, Inc. The market is driven by the increasing incidence of
infertility owing to, lifestyle changes, expansion of fertility procedures for
treating male infertility such as ICSI, government initiatives to provide
better reimbursement policies, and continuous efforts by the industry
contributors.
Moreover, the availability of genomic
testing enabling the prevention of the transfer of genetic disease during IVF
use is further expected to drive the market demand. The increase in the number
of IVF treatment has led more insurance players to cover the IVF procedures.
This has ultimately led to competitive pricing and has moderated the treatment
costs as IVF has been a successfully practiced technology. This will most
likely drive the market by introducing treatment standardization and
automation.
The behavioral shift in the society is a
major factor contributing to the decreased Total Fertility Rate (TFR). These factors
include an increasing number of women in the labor force, the increased age of
the first birth, a shift from rural to urban societies, lower marriage rates,
postponement of marriage, and greater levels of education for women.
Obesity is another factor, which has led to
an increase in infertility in the population. This is due to the fact that the
fat deposited on women’s abdomen prevents follicular stimulation and produces
male hormones. In the case of males, the rising fat decreases testosterone levels
causing a problem in sperm production. Doctors have started recommending weight
loss in men prior to fertility treatments along with proper Body Mass Index
(BMI) maintenance. The U.S. Endocrine Society has established the use of
Letrozole to increase the testosterone levels in obese patients.
Full Research Report On In-Vitro Fertilization (IVF) Market Analysis:
http://www.grandviewresearch.com/industry-analysis/in-vitro-fertilization-market
http://www.grandviewresearch.com/industry-analysis/in-vitro-fertilization-market
Further key findings from the report suggest:
·
Intracytoplasmic Sperm Injection (ICSI)
dominated the market in 2014.ICSI was introduced in the year 1992 and boosted
the fertility rates from 50% to 80%, according to the American Society for
Reproductive Medicine. In April 2016, Nigeria recorded its first successful
delivery from a frozen egg. Bridge Clinic has stored the eggs using the
flash-freezing technique. With this birth, Nigeria has put itself on the global
map as it now offers IVF through frozen eggs. The eggs were then fertilized
using the ICSI technique.
·
Frozen Embryo Replacement (FER) technique
is expected to witness a rapid rise in demand. Conventionally, most embryos
were transferred through fresh cycles. However, with technology refinement, the
number of frozen embryo transfers and the success rates have increased.
Moreover, the policy of freezing the embryos has also reduced the chances of
ovarian hyper-stimulation. The frozen embryo transfers enable single egg
transfer, thus, giving enough time for the endometrial layer to heal from the
medicine stimulation effect. This ensures higher success rates.
·
Culture media dominated the overall market
in terms of revenue in 2014. With the increasing government funding and
industrial support for employees for egg/sperm freezing, the demand for
cryopreservation and the needed media for it is expected to witness growth.
There has been an increase in the research activities undertaken to improve the
culture media and to procure maximum boar sperms or eggs, spurring market
growth. Moreover, the increasing number of egg/sperm donor banks is expected to
drive the demand for sperm, egg, and embryo processing media during the
forecast period.
·
Europe dominated the IVF market in 2014.
High quality of treatment offered at the most economical price, and the
adherence to medical standards have contributed to its market leadership. In
Europe, the NHS covers three IVF cycles and has also started providing coverage
for gametes freezing. Moreover, the region is an attraction for international
clients as countries, such as Spain, have the highest number of egg donors. The
clinics also provide sex identification and other IVF treatments, which are not
offered in North America.
·
North America also accounted for a
significant share of the market in 2014. The standardization of procedures
through automation, regulatory reforms, government funding for egg/sperm
storage, and industry players introducing more IVF treatments are some
contributing factors for North America dominating the IVF market.
·
The presence of favorable reimbursement
framework (implementation of USD 50 million 5-year plans by the U.S Department
of Defense for sperm/egg freezing coverage) is also expected to drive regional
market growth over the next six years. The increasing number of clinics
undertaking newer industrial techniques to offer better fertility success rates
is also expected to boost the regional market demand.
·
The demand for IVF treatment is expected to
boom in APAC owing to fertility tourism, increasing foreign industries trying
to penetrate the economically developing countries and the changing regulatory
landscape.
·
The Asia Pacific Initiative on Reproduction
(ASPIRE), the task force of clinicians and scientists is involved in the
monitoring and management of fertility and Assisted Reproductive Technology
(ART). Such initiatives promote awareness levels thereby, driving growth.
·
Industry contributors are introducing newer
automation to shift the IVF treatment from invasive to a minimally invasive or
non-invasive procedure. The industry players are also trying technologies,
which can enable older women to have enhanced fertility rates. For instance, in
August 2015, OvaScience announced the results of its first published analysis
comparing AUGMENT fertility treatment with a standard IVF. The results showed a
significantly higher rate of selection and transfer of embryos as compared to
the standard treatment.
·
Some key players in this market includeEMD
Serono Inc., Boston IVF, OvaScience, Thermo Fisher Scientific Inc., Vitrolife
AB, Irvine Scientific, CooperSurgical, Inc., Cook Medical Inc., Genea Biomedx
and Progyny Inc.
Browse
More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the In-Vitro Fertilization (IVF)
market on the basis of procedures, type of cycles, instruments, end-use, and
regions:
Global In-Vitro Fertilization (IVF)
Procedures Outlook (Revenue, USD Million, 2012 - 2022)
·
Intracytoplasmic Sperm Injection (ICSI)
·
Frozen Embryo Replacement (FER)
·
Pre-implantation Genetic Diagnosis (PGD)
·
Others
Global In-Vitro Fertilization (IVF) Types
of Cycles Outlook (Revenue, USD Million, 2012 - 2022)
·
Fresh Donor
·
Frozen Donor
·
Fresh Non-donor
·
Frozen Non-donor
Global In-Vitro Fertilization (IVF)
Instruments Outlook (Revenue, USD Million, 2012 - 2022)
·
IVD Disposable Devices
·
Culture Media
·
Capital Equipment
In-Vitro Fertilization (IVF) Regional
Outlook (Revenue, USD Million, 2012 - 2022)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
o
France
o
Rest of Europe
·
Asia Pacific
o
India
o
Japan
o
China
o
Rest of Asia Pacific
·
Latin America
o
Brazil
o
Mexico
o
Rest of Latin America
·
MEA
o
South Africa
o
Rest of MEA
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-ivf-market
www.grandviewresearch.com/press-release/global-ivf-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/
No comments:
Post a Comment